ライフサイエンスコーパス: hypogonadism

1 nction, delayed puberty and hypogonadotropic hypogonadism).

2 f the hypothalamic-pituitary unit (secondary hypogonadism).

3 ads to a strong meiotic phenotype and severe hypogonadism.

4 tigate the pathogenesis of hypogonadotrophic hypogonadism.

5 unctions absent in patients with hypogonadal hypogonadism.

6 um criteria necessary to identify late-onset hypogonadism.

7 exhibit subfertility due to hypogonadotropic hypogonadism.

8 g recognized in males and is associated with hypogonadism.

9 erlapping features of impaired olfaction and hypogonadism.

10 he rare adult-onset form of hypogonadotropic hypogonadism.

11 ransplant recipients should be evaluated for hypogonadism.

12 and delayed puberty due to hypogonadotropic hypogonadism.

13 germ cells to progress through meiosis I and hypogonadism.

14 ced effect on the prostate in a rat model of hypogonadism.

15 the hypothalamus as well as hypogonadotropic hypogonadism.

16 SHR) null mice have bone loss despite severe hypogonadism.

17 ivation therapy (ADT), resulting in profound hypogonadism.

18 loss of sense of smell and hypogonadotrophic hypogonadism.

19 y adrenal insufficiency and hypogonadotropic hypogonadism.

20 hormone replacement therapy as indicated for hypogonadism.

21 lative effect of estrogen status compared to hypogonadism.

22 d primary hypogonadism and two had secondary hypogonadism.

23 sk of prostate cancer in men with late-onset hypogonadism.

24 beta gene, which causes Q54 to be R, causes hypogonadism.

25 roduce less testosterone, leading to primary hypogonadism.

26 e intervention in older men with obesity and hypogonadism.

27 upted vaginal cycling, and hypergonadotropic hypogonadism.

28 myelination, hypodontia and hypogonadotropic hypogonadism.

29 oidism, hypoadrenalism, and hypogonadotropic hypogonadism.

30 me a promising prospect for treating primary hypogonadism.

31 ed body mass, reduced physical activity, and hypogonadism.

32 d if dysfunctional leads to Hypogonadotropic Hypogonadism.

33 y, intellectual disability, polydactyly, and hypogonadism.

34 ase, although it is often in part related to hypogonadism.

35 ann syndrome and idiopathic hypogonadotropic hypogonadism.

36 oportionate short stature, microcephaly, and hypogonadism.

37 ypothalamic amenorrhea, and hypogonadotropic hypogonadism.

38 rrhea, hypothyroidism, and hypergonadotropic hypogonadism.

39 a, uterine hypoplasia, and hypergonadotropic hypogonadism.

40 health in relation to testosterone and male hypogonadism.

41 aracterized by anosmia and hypogonadotrophic hypogonadism.

42 ctions, such as potency and libido, to avoid hypogonadism.

43 cts of the medications as opposed to chronic hypogonadism.

44 sk of prostate cancer in men with late-onset hypogonadism.

45 and pubertal failure due to hypogonadotropic hypogonadism.

46 range and reported no increased symptoms of hypogonadism.

47 g ADT and in elderly men with age-associated hypogonadism.

48 steoporosis caused by chronic opioid-induced hypogonadism.

49 hs, that underlies typical hypogonadotrophic hypogonadism.

50 rophin deficiency known as hypogonadotrophic hypogonadism.

51 unction of the reproductive axis and causing hypogonadism.(1-4) Thirteen-lined ground squirrels (Icti

52 sterone deficiency (30%-50%) and symptomatic hypogonadism (15%) in men with HF is significant.

53 bnormal reproductive hormones: 4 had primary hypogonadism, 2 had secondary hypogonadism, and 1 develo

54 D] body mass index, 33.5 [7.3]), 116 men had hypogonadism, 427 had eugonadism, and 180 were receiving

55 ta suggest that in aging men with late-onset hypogonadism, 6 months of TRT normalizes serum androgen

56 enes involved in idiopathic hypogonadotropic hypogonadism, a congenital form of GnRH deficiency, are

57 of GPR54 causes idiopathic hypogonadotropic hypogonadism, a disorder characterized by delayed pubert

58 In congenital hypogonadotropic hypogonadism, a lack of gonadotropin activity results pr

59 hormonal changes were simulated by inducing hypogonadism, adding back estradiol (E2) and progesteron

60 nsipidus, growth hormone deficiency, primary hypogonadism, adrenal insufficiency, and hypothyroidism.

61 Reduced serum testosterone (T), or hypogonadism, affects millions of men and is associated

62 infertility accompanied by hypergonadotropic hypogonadism after 30 weeks of age.

63 mong 50 men with idiopathic hypogonadotropic hypogonadism after a mean (+/-SD) duration of treatment

64 y hyperphagia, obesity and hypogonadotrophic hypogonadism, all highly suggestive of hypothalamic dysf

65 der that is associated with hypogonadotropic hypogonadism also.

66 In conclusion, hypogonadism, although common among men older than 54 ye

67 Hypogonadism, an acquired endocrine deficiency state cha

68 adotropes is delayed, resulting in transient hypogonadism and a delay in the onset of puberty.

69 In middle-aged and older men with hypogonadism and anemia, TRT was more efficacious than p

70 include Kallmann syndrome (hypogonadotropic hypogonadism and anosmia), stereotyped midface hypoplasi

71 drome, a condition characterized by obesity, hypogonadism and behavioral abnormalities, the expressio

72 POF presents as hypergonadotropic hypogonadism and can be part of a syndrome or occur in i

73 e disease characterized by hypogonadotrophic hypogonadism and cardiomyopathy.

74 Although the bidirectional link between hypogonadism and cardiovascular disease has been clarifi

75 mild of form of FA-like phenotypes including hypogonadism and cellular sensitivity to the crosslinker

76 reminiscent of isolated LH-hypogonadotropic hypogonadism and corpus luteum insufficiency in humans.

77 pectrum of endocrine abnormalities including hypogonadism and feminization, with elevated serum estra

78 ncy results in stunted growth, skin lesions, hypogonadism and frequent infections in humans.

79 , as well as severe germline defects such as hypogonadism and germ cell depletion.

80 for fat-free mass, partial hypogonadotropic hypogonadism and growth failure.

81 al bilateral anophthalmia, hypogonadotrophic hypogonadism and growth hormone deficiency.

82 ascular disease and who reported symptoms of hypogonadism and had two fasting testosterone levels of

83 formation leading to high bone mass despite hypogonadism and hypercortisolism.

84 ent approaches that should be considered for hypogonadism and hypoadrenalism.

85 ic disease characterized by hypogonadotropic hypogonadism and impaired sense of smell.

86 ic hypogonadism (IHH) is a rare disease with hypogonadism and infertility caused by the defects in em

87 is in GnRH neurons leads to hypogonadotropic hypogonadism and infertility in mice.

88 treatment of CFRD, CFBD, growth and puberty, hypogonadism and infertility, iatrogenic adrenal insuffi

89 set of puberty and leads to hypogonadotropic hypogonadism and infertility.

90 ice lacking miR-7a2 develop hypogonadotropic hypogonadism and infertility.

91 ecocious germline differentiation leading to hypogonadism and infertility.

92 iss1r (Kiss1r(d/d)) display hypogonadotropic hypogonadism and infertility.

93 cross-sectional study examines prevalence of hypogonadism and its correlation with QoL and sexual dys

94 luding causes of idiopathic hypogonadotropic hypogonadism and Kallmann syndrome.

95 Both hypogonadism and low estrogen levels adversely affect bo

96 MSG treatments induced hypogonadism and obesity, retain-->and markedly reduced

97 ess, and the use of testosterone in men with hypogonadism and obesity.

98 characterized by idiopathic hypogonadotropic hypogonadism and olfactory dysfunction.

99 astatic prostate cancer are at risk for both hypogonadism and osteoporosis.

100 in an individual with hyperphagia, obesity, hypogonadism and other features associated with PWS, whi

101 In men with hypogonadism and preexisting or a high risk of cardiovas

102 metabolic syndrome, cardiovascular disease, hypogonadism and psychosocial issues, and might yield gr

103 Treatment with GnRH reversed the hypogonadism and restored fertility in each of the five

104 ssive loss of male fertility, accompanied by hypogonadism and seminal vesicle agenesis/hypodysplasia.

105 DNF) involved in congenital hypogonadotropic hypogonadism and several types of cancer.

106 y syndrome associated with hypergonadotropic hypogonadism and short stature.

107 ith CSF measures of androsterone during both hypogonadism and testosterone replacement (r = -0.76 and

108 sal of normosmic idiopathic hypogonadotropic hypogonadism and the Kallmann syndrome was noted after d

109 ression models to examine the association of hypogonadism and time to depression diagnosis, adjusting

110 e of hypogonadism pre-PTX: three had primary hypogonadism and two had secondary hypogonadism.

111 4 had primary hypogonadism, 2 had secondary hypogonadism, and 1 developed hyperestrogenemia with ele

112 rain anomalies, heart defects, macrocephaly, hypogonadism, and additional features with variable expr

113 g resolution of type 2 diabetes mellitus and hypogonadism, and beneficial effects on ingestive and no

114 published studies relating to testosterone, hypogonadism, and HF and provide practical clinical info

115 e molecular mechanisms of vascular injury in hypogonadism, and identify hypospadias as a cardiovascul

116 which includes hyperphagia, severe obesity, hypogonadism, and impaired immunity, has provided insigh

117 y, congenital malformations of the skeleton, hypogonadism, and increased risk of leukemia.

118 gies, including hyperphagia-induced obesity, hypogonadism, and learning and memory deficits.

119 phenotypes are hyperphagic obesity, central hypogonadism, and low growth hormone (GH).

120 ignificantly more growth hormone deficiency, hypogonadism, and neuropathy than controls.

121 one parameters, menstrual cycle, symptoms of hypogonadism, and offspring were evaluated.

122 /134; 9.0%]) and mostly included withdrawal, hypogonadism, and overdose.

123 oxicity, neurotoxicity, decreased fertility, hypogonadism, and psychosocial problems.

124 ally reduced mating frequency and fertility, hypogonadism, and reduced serum testosterone.

125 tional risk factors such as low body weight, hypogonadism, and smoking, as well as direct effects of

126 te, testicular, or male breast cancer; known hypogonadism; and HIV.

127 diovascular disease; one or more symptoms of hypogonadism; and two morning testosterone concentration

128 Both obesity and hypogonadism are common in older men which could additiv

129 associated with idiopathic hypogonadotropic hypogonadism are found in women with hypothalamic amenor

130 mutants from patients with hypogonadotropic hypogonadism are frequently misrouted proteins that exer

131 Male hypogonadism, arising from a range of etiologies includi

132 g body of evidence suggests the role of male hypogonadism as a possible harbinger for poor clinical o

133 ciency, central diabetes insipidus, and male hypogonadism as new features of PCSK1 insufficiency.

134 ined reversal of idiopathic hypogonadotropic hypogonadism as the presence of normal adult testosteron

135 palatal abnormalities, ventriculomegaly, and hypogonadism as well as additional findings such as bone

136 e randomly assigned 1199 men with primary or hypogonadism-associated osteoporosis who were 50 to 85 y

137 , placebo-controlled trial included men with hypogonadism at 316 US sites enrolled between May 2018 a

138 The syndrome of hypogonadotropic hypogonadism, ataxia, and dementia can be caused by inac

139 An alternate definition of hypogonadism based only on a mean testosterone level les

140 of 12,779 men who were newly diagnosed with hypogonadism between January 1, 1995, and August 31, 201

141 ted PRL may not only improve infertility and hypogonadism but also have a positive effect on the meta

142 Late-onset hypogonadism can be defined by the presence of at least

143 population of middle-aged and older men with hypogonadism, carefully evaluated to exclude those at hi

144 ia of prepubertal onset and hypogonadotropic hypogonadism caused by elevated estrogen levels.

145 (NKB) and its receptor show hypogonadotropic hypogonadism characterised by failure to progress throug

146 ptor, NK3 (NK3R), result in hypogonadotropic hypogonadism, characterized by an absence of pubertal de

147 Congenital hypogonadotropic hypogonadism (CHH) is a condition characterized by absen

148 s (n = 337) with congenital hypogonadotropic hypogonadism (CHH) showed enrichment of rare variants in

149 ns, resulting in congenital hypogonadotropic hypogonadism (CHH), a heterogeneous disease characterize

150 thus raising the hypothesis that ADT-induced hypogonadism could potentially lead to acute kidney inju

151 eficient in PC1 display hyperphagic obesity, hypogonadism, decreased GH, and hypoinsulinemic diabetes

152 mple, patients exhibit obesity, polydactyly, hypogonadism, developmental delay and skeletal abnormali

153 Short-term hypogonadism did not affect VLDL triglyceride (TG) secre

154 We recently reported that hypogonadism does not affect respiratory muscle performa

155 In conclusion, hypogonadism does not decrease respiratory or limb muscl

156 nactivation of Kiss1 causes hypogonadotropic hypogonadism, Donato et al., in this issue of the JCI, a

157 However, the cardiovascular impact of hypogonadism during development is unknown.

158 rogeneous and manifests as hypergonadotropic hypogonadism either as part of a syndrome or in isolatio

159 ale fertility are multifactorial and include hypogonadism, erectile dysfunction, sperm abnormalities,

160 dy androgen receptor (AR)-knockout mice with hypogonadism exhibit insulin resistance.

161 ation (GnRHR E(90)K) causes hypogonadotropic hypogonadism (failed puberty associated with low or apul

162 n a patient with ataxia and hypogonadotropic hypogonadism, followed by targeted sequencing of candida

163 Hypogonadism, found in about one-third of patients with

164 sm, central hypothyroidism, hypogonadotropic hypogonadism, growth hormone deficiency, or arginine vas

165 la, malignant hyperthermia, hypogonadotropic hypogonadism, growth retardation, hypoglycemia, myopathy

166 eterogeneous, frequently have not adhered to hypogonadism guidelines, and suffer from many intrinsic

167 sufficiency and associated hypogonadotrophic hypogonadism had a measurable response to gonadotropin-r

168 After multivariable adjustment, men with hypogonadism had higher odds than men with eugonadism of

169 iency, men with adult-onset hypogonadotropic hypogonadism had larger mean (+/-SD) testicular volumes

170 or pituitary hypoplasia and hypogonadotropic hypogonadism, has been reported in patients carrying SOX

171 oplasia congenita (AHC) and hypogonadotropic hypogonadism (HH).

172 oplasia congenita (AHC) and hypogonadotropic hypogonadism (HH).

173 Hypogonadotropic hypogonadism (HHG) has been identified as a component of

174 ilar to patients with AS, including obesity, hypogonadism, hyperinsulinemia, retinal dysfunction and

175 splay growth deficiencies as adolescents and hypogonadism, hyperphagia, and obesity as adults.

176 ormal glucose homeostasis, hypogonadotrophic hypogonadism, hypocortisolism and elevated plasma proins

177 nally observed include acanthosis nigricans, hypogonadism, hypothyroidism, alopecia, short stature an

178 rweight or obesity, bone mineral deficiency, hypogonadism, hypothyroidism, and adrenal insufficiency,

179 The crude prevalence of hypogonadism (ie, TT < 300 ng/dL) was 48%, and mean TT i

180 er consisting of idiopathic hypogonadotropic hypogonadism (IHH) and anosmia, and is most commonly due

181 e the phenotype of isolated hypogonadotropic hypogonadism (IHH) associated with variants of these gen

182 Idiopathic hypogonadotropic hypogonadism (IHH) due to defects of gonadotropin-releas

183 Idiopathic hypogonadotropic hypogonadism (IHH) is a condition characterized by failu

184 Isolated hypogonadotropic hypogonadism (IHH) is a rare disease with hypogonadism a

185 Isolated hypogonadotropic hypogonadism (IHH) is caused by defective gonadotropin-r

186 Idiopathic hypogonadotropic hypogonadism (IHH) with anosmia (Kallmann syndrome; KS)

187 in families with idiopathic hypogonadotropic hypogonadism (IHH).

188 associated with idiopathic hypogonadotropic hypogonadism in 55 women with hypothalamic amenorrhea an

189 and could be used to treat men with primary hypogonadism in a more specific and personalized approac

190 hypogonadal state were simulated by inducing hypogonadism in euthymic women-eight with and eight with

191 short-term estradiol withdrawal and induced hypogonadism in healthy premenopausal women.

192 t to describe the effects on mood of induced hypogonadism in healthy young men, suggest that short-te

193 osomal recessive idiopathic hypogonadotropic hypogonadism in humans and mice, suggesting that this re

194 or deletions of GPR54 cause hypogonadotropic hypogonadism in humans and mice.

195 in the FSHB/Fshb gene cause hypogonadotropic hypogonadism in humans and mice.

196 The prevalence of symptomatic hypogonadism in male patients with cancer exceeds that f

197 r adrenal insufficiency and hypogonadotropic hypogonadism in males affected by adrenal hypoplasia con

198 Obesity is associated with hypogonadism in males, characterized by low testosterone

199 strophy, deafness, mandibular hypoplasia and hypogonadism in males.

200 recognition of adult-onset hypogonadotropic hypogonadism in men as a distinct disorder expands the s

201 lated testosterone deficiency and late-onset hypogonadism in men remains a controversial concept.

202 short-term treatment of symptoms of clinical hypogonadism in men with symptomatic human immunodeficie

203 l testosterone, free testosterone, SHBG, and hypogonadism in men within the Million Veteran Program (

204 the approach to evaluation and management of hypogonadism in men.

205 , and acute treatment substantially corrects hypogonadism in mice starved for 2 d without affecting b

206 on on proper diagnosis and treatment of male hypogonadism in patients with HF.

207 ation for the occurrence of hypogonadotropic hypogonadism in patients with inactivating mutations in

208 However, treating hypogonadism in the aging male has resulted in discrepan

209 ce-based criteria for identifying late-onset hypogonadism in the general population on the basis of a

210 tients had hypothyroidism, hypergonadotropic hypogonadism (in men), pulmonary insufficiency, swallowi

211 ry, and swallowing function; muscle atrophy; hypogonadism (in men); retinopathy; vascular and cerebra

212 vere obesity, mild learning difficulties and hypogonadism, in whom diagnostic tests for Prader-Willi

213 f growth-hormone deficiency, hypothyroidism, hypogonadism, infertility, and cataracts.

214 adenomas are prolactinomas, which can cause hypogonadism, infertility, and/or galactorrhea.

215 including kyphosis, uncoordinated movement, hypogonadism, infertility, severe skeletal muscle wastin

216 st neonatal hypotonia, feeding difficulties, hypogonadism, intellectual disability and sleep apnea.

217 Late-onset hypogonadism is a clinical condition in the ageing male

218 Male hypogonadism is a clinical syndrome that results from fa

219 Hypogonadism is a major risk factor.

220 Because male hypogonadism is a risk factor for metabolic syndrome and

221 Hypogonadism is associated with cardiovascular disease.

222 Although a high prevalence of hypogonadism is associated with opioid use, HIV and tran

223 Male hypogonadism is defined as low circulating testosterone

224 The clinical diagnosis of hypogonadism is made on the basis of signs and symptoms

225 to assess reversibility of hypogonadotropic hypogonadism is reasonable.

226 n healthy young men, suggest that short-term hypogonadism is sufficient to precipitate depressive sym

227 Hypogonadism is the most well recognised consequence of

228 cancer, diabetes mellitus, hypogonadotrophic hypogonadism, joint disease, and cardiomyopathy.

229 Hypogonadism may arise from testicular disease (primary

230 of hospitalization differs between men with hypogonadism, men with eugonadism, and those receiving t

231 nia, childhood obesity, dysmorphic features, hypogonadism, mental retardation, and behavioral problem

232 oly/syn/brachydactyly, retinal degeneration, hypogonadism, mental retardation, obesity, diabetes, and

233 Testosterone therapy for congenital forms of hypogonadism must be lifelong, whereas testosterone trea

234 = 2), myelodysplastic syndrome (n = 2), and hypogonadism (n = 4).

235 Screening and appropriate therapy for hypogonadism need to be evaluated as a strategy to preve

236 nd whether specific symptoms associated with hypogonadism (nighttime hot flushes and disturbed sleep)

237 her as normosmic idiopathic hypogonadotropic hypogonadism (nIHH) or with anosmia [Kallmann syndrome (

238 for osteoporotic fracture, the influence of hypogonadism on bone mineral density remains unclear, as

239 ngly, we determined prevalence and impact of hypogonadism on health-related quality of life in men wi

240 larly if high index of clinical suspicion of hypogonadism or hypoadrenalism) and evaluation of bone h

241 on (OR, 1.70, 95% CI, 1.19-2.44; AF, 11.5%), hypogonadism (OR, 3.27, 95% CI, 2.35-4.55; AF, 25.1%), g

242 m may arise from testicular disease (primary hypogonadism) or dysfunction of the hypothalamic-pituita

243 myelination, Hypodontia and Hypogonadotropic Hypogonadism) or RNA polymerase III (POLR3)-related leuk

244 , including kyphosis, severe muscle wasting, hypogonadism, osteopenia, emphysema, uncoordinated movem

245 tion in TACR3 for idiopathic hypogonatrophic hypogonadism (p.W275X) is associated with 1.25-year-late

246 erone levels were significantly lower during hypogonadism (P=.002, .04, and .046, respectively), but

247 f opioids rather than chronic opioid-induced hypogonadism play a key role in fracture risk.

248 Two men had secondary hypogonadism pre-PTX with resolution in one and persiste

249 Five of the ten women had evidence of hypogonadism pre-PTX: three had primary hypogonadism and

250 ogen receptors; and (2) such alcohol-induced hypogonadism precedes changes in hepatic sex hormone hom

251 30 days of alcohol exposure, suggesting that hypogonadism precedes liver feminization.

252 scular calcification, severe muscle wasting, hypogonadism, pulmonary emphysema, distention of intesti

253 levels between testosterone replacement and hypogonadism (r = -0.68; P<.05).

254 In elderly men, hypogonadism related to aging has little influence on bo

255 ce, a syndrome emerged with delayed puberty, hypogonadism, relative macrocephaly, moderate short stat

256 Controlling for all covariates, hypogonadism remained significantly associated with depr

257 whereas testosterone treatment of late-onset hypogonadism remains a matter of debate because of uncle

258 by retinal dystrophy, polydactyly, obesity, hypogonadism, renal abnormalities, and mental retardatio

259 besity, pigmentary retinopathy, polydactyly, hypogonadism, renal and cardiac abnormalities, and cogni

260 y, hepatic dysfunction, hypothyroidism, male hypogonadism, short stature and mild to moderate develop

261 deficient mice had isolated hypogonadotropic hypogonadism (small testes in male mice and a delay in v

262 ing, is characterized by neonatal hypotonia, hypogonadism, small hands and feet, hyperphagia and obes

263 Age-associated hypogonadism (testosterone deficit) occurs in 30% of men

264 stablished medical conditions known to cause hypogonadism, testosterone therapy may provide small imp

265 Among middle-aged and older men with hypogonadism, testosterone treatment did not result in a

266 No cases of secondary hypogonadism that developed or resolved post-PTX were re

267 lt-onset form of idiopathic hypogonadotropic hypogonadism that develops after puberty.

268 re a novel genetic model of hypogonadotropic hypogonadism that establishes essential role(s) of SF1 i

269 When it comes to managing men with hypogonadism, the benefit of testosterone replacement th

270 development and congenital hypogonadotropic hypogonadism, the European Union has funded a number of

271 nverse energy, such as inducing hypothalamic hypogonadism to prevent fertilization.

272 adult onset of obesity and hypogonadotropic hypogonadism to study effects of gonadotropin releasing

273 Among older men with symptomatic hypogonadism, treatment with testosterone gel for 1 year

274 ssors and the development of obesity-induced hypogonadism, underscoring the physiological and patholo

275 -producing cells that could be used to treat hypogonadism via transplantation and reestablishment of

276 unadjusted hazard ratio for depression with hypogonadism was 3.5 (95% confidence interval, 1.3-9.4)

277 Relative to baseline, induced hypogonadism was associated with significantly decreased

278 Hypogonadism was defined as a mean testosterone level le

279 Hypogonadism was defined as a total testosterone concent

280 ted proband with idiopathic hypogonadotropic hypogonadism was determined to have two separate mutatio

281 The combination of ataxia and hypogonadism was first described more than a century ago

282 Idiopathic hypogonadotropic hypogonadism was previously thought to require lifelong

283 plasia congenita (AHC) with hypogonadotropic hypogonadism was recently shown to be caused by mutation

284 ADT-induced hypogonadism was reported to have the potential to lead

285 Among those whose hypogonadism was reversed, the mean serum level of endog

286 whom reversal of idiopathic hypogonadotropic hypogonadism was sustained after discontinuation of horm

287 The prevalence of hypogonadism was unexpectedly high.

288 Hypogonadism was untreated in 50% of men and 20% of wome

289 A similar model that adjusted for hypogonadism was used to examine the association of estr

290 tal development (idiopathic hypogonadotropic hypogonadism) was examined for mutations in a candidate

291 treatment in middle-aged and older men with hypogonadism, we examined the risk of clinical fracture

292 Men with hypogonadism were more likely than men with eugonadism t

293 P > 0.2), even when alternate definitions of hypogonadism were used.

294 Idiopathic hypogonadotropic hypogonadism, which may be associated with anosmia (the

295 to testosterone) and symptoms suggestive of hypogonadism who were enrolled in the Testosterone Trial

296 The association of hypogonadism with bone mineral density was examined with

297 sing hormone (GnRH) that is characterized by hypogonadism with delayed or absent puberty and dysfunct

298 PR54 genes cause idiopathic hypogonadotropic hypogonadism with normal olfaction (nIHH).

299 patients who had idiopathic hypogonadotropic hypogonadism without GPR54 mutations.

300 ed with improved IIEF score in patients with hypogonadism (WMD, 1.61; 95% CI, 0.99-2.23; I2 = 0%), mo